Pregabalin Market size was valued at US$ 770.65 Mn. in 2021 and is expected to grow at a CAGR of 3.69% through 2022 to 2029. Neuropathic Pain segment leads the Global Pregabalin Market by 2029.
Pregabalin Market Overview:The Global Pregabalin market was valued at US$ 770.65 Mn. in 2021, and it is expected to reach US$ 1029.8 Mn. by 2029 with a CAGR of 3.69% during the forecast period. Pregabalin is an anticonvulsant and anxiolytic drug that is used to treat a variety of disorders, including epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, and generalised anxiety disorder. It's a type of epilepsy treatment that's used to treat partial seizures. When given before surgery, it reduces pain but also causes sleepiness and visual disturbances of epilepsy patients live in low- and middle-income countries during the early stages of the disease. To know about the Research Methodology :- Request Free Sample Report However, growth in the incidence rate of heart, kidney, liver, and type II diabetes will boost the global pregabalin market. Furthermore, the involvement of significant firms in R&D, numerous healthcare investments, and a number of product launches gloves provide opportunistic prospects in the development of the pregabalin market in the area. In recent years, the government has enacted regulatory procedures and imposed tariffs on the manufacture and distribution of Pregabalin in the drug market due to a variety of health issues. This is expected to drive market growth throughout the forecast period. On the other side, the FDA's approval of generic versions of the medicine increases drug availability while lowering market revenue. The availability of alternatives, adverse effects, and rigorous regulatory constraints are all expected to stifle pregabalin's growth.
Pregabalin Market Segment Analysis:The Global Pregabalin Market is segmented by Product and Application. Based on the Product, the market is segmented into Capsules, Oral Solutions, and Others. The oral Solutions pregabalin segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2029. Oral Solutions pregabalin aids in the control of some types of seizures. It's a drug that's used to relieve nerve discomfort. Fibromyalgia is treated with it. It could be given to you for a variety of reasons. These are the key factors of oral solutions pregabalin that boost the growth of the global market during the forecast period 2022-2029. Based on the Applications, the market is segmented into Epilepsy, Neuropathic Pain, Anxiety Disorders, and Others. The neuropathic Pain segment is expected to hold the largest market share of xx% by 2029. Burning or shooting pain is a common symptom of neuropathic pain. Nerve injury is the most common cause. Pregabalin works by inhibiting pain signals and thereby reducing neuropathic pain. The market is expected to develop due to rising incidences of neuropathic pain and rising risk factors such as diabetes and HIV. According to the International Diabetes Federation, diabetes affects 9.3 % of the adult population worldwide in 2019, with the number expected to rise to about 11 % by 2045. Furthermore, according to a National Institute of Health report from 2019, diabetic polyneuropathy (DPN) is the most frequent diabetic consequence, with a lifetime frequency of nearly 50%. Neuropathic pain affects about 20 to 30% of DPN patients. Furthermore, the patent expiration of Viatris Inc's Lyrica (pregabalin) in 2019 increased the market share of generic medicine producers. Furthermore, the market is expected to develop due to ongoing R&D into increasing the applications of pregabalin in various disease therapies, as well as new product introductions. These are the key factors that boost the growth of this segment in the Global Pregabalin market during the forecast period 2022-2029.
Global Pregabalin Market Regional Insights:North America dominates the Global Pregabalin market during the forecast period 2022-2029. North America is expected to hold the largest market share of xx% by 2029. Chronic disease is becoming more common, and well-established healthcare infrastructure, widespread use of new technology, and government efforts to compel the upkeep of health data are all contributing to this rise. Due to the increased prevalence of disorders such as neuropathy, diabetes, and HIV, pregabalin is in great demand among the elderly. Peripheral neuropathy affects 47% of diabetic individuals, according to a big American study. Neuropathy is predicted to be present in 7.5% of diabetic individuals at the time of diagnosis. More than half of all cases of polyneuropathy are distal symmetric polyneuropathy. These are the major factor that drives the growth of this region in the global market during the forecast period 2022-2029. The objective of the report is to present a comprehensive analysis of the GlobalPregabalin Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the GlobalPregabalin Market dynamic, structure by analyzing the market segments and project the GlobalPregabalin Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the GlobalPregabalin Market make the report investor’s guide.
Pregabalin Market Scope: Inquire before buying
Global Pregabalin Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 770.65 Mn. Forecast Period 2022 to 2029 CAGR: 3.69% Market Size in 2029: US $ 1029.8 Mn. Segments Covered: by Product • Capsules • Oral Solutions • Others by Application • Epilepsy • Neuropathic Pain • Anxiety Disorders • Others
Global Pregabalin Market, by Region• North America • Europe • Asia Pacific • South America • Middle East and Africa
Global Pregabalin Market Key Players• Pfizer Inc. • Torrent Pharmaceuticals Ltd. • Lupin Limited • Zydus Cadila Healthcare Ltd. • Cipla Limited • Genesis Remedies • Sanofi • Medley Pharmaceuticals Limited • Genesis Biotec Inc. • Biomax • ZCL Chemicals Ltd. • Olon S.p.A. • AASraw Biochemical Technology Co., Ltd. • Changzhou Pharmaceutical Factory (CPF) • Almelo Pvt. Ltd. • Angels Pharma India Pvt. Ltd. • ARITE Pharmaceutical Co., Ltd. • Bal Pharma Limited. • Bazayan and Co. • Aurobindo Pharma Ltd. • Hikal Ltd. • Glenmark Life Sciences • Dongbang FTL
Frequently Asked Questions:1] What segments are covered in Global Pregabalin Market report? Ans. The segments covered in Global Pregabalin Market report are based on Product, and Application. 2] Which region is expected to hold the highest share in the Global Pregabalin Market? Ans. North America is expected to hold the highest share in the Global Pregabalin Market. 3] Who are the top key players in the Global Pregabalin Market? Ans. Pfizer Inc., Torrent Pharmaceuticals Ltd., Lupin Limited, Zydus Cadila Healthcare Ltd., and Cipla Limited are the top key players in the Global Pregabalin Market. 4] Which segment held the largest market share in the Global Pregabalin market by 2021? Ans. Neuropathic Pain segment held the largest market share in the Global Pregabalin market by 2021. 5] What is the expected market size of the Global Pregabalin market by 2029? Ans. The forecast market size of the Global Pregabalin market is US$ 1029.8 Mn. by 2029. 6] What was the market size of the Global Pregabalin market in 2021? Ans. The market size of the GlobalPregabalin market was worth US $ 770.65 Mn. in 2021.
1. Global Pregabalin Market: Research Methodology 2. Global Pregabalin Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Pregabalin Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Pregabalin Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Pregabalin Market Segmentation 4.1 Global Pregabalin Market, by Product (2021-2029) • Capsules • Oral Solutions • Others 4.2 Global Pregabalin Market, by Application (2021-2029) • Epilepsy • Neuropathic Pain • Anxiety Disorders • Others 5. North America Pregabalin Market (2021-2029) 5.1 Global Pregabalin Market, by Product (2021-2029) • Capsules • Oral Solutions • Others 5.2 Global Pregabalin Market, by Application(2021-2029) • Epilepsy • Neuropathic Pain • Anxiety Disorders • Others 5.3 North America Pregabalin Market, by Country (2021-2029) • United States • Canada • Mexico 6. Asia Pacific Pregabalin Market (2021-2029) 6.1. Asia Pacific Pregabalin Market, by Product(2021-2029) 6.2. Asia Pacific Pregabalin Market, by Application(2021-2029) 6.3. Asia Pacific Pregabalin Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Pregabalin Market (2021-2029) 7.1 Middle East and Africa Pregabalin Market, by Product(2021-2029) 7.2. Middle East and Africa Pregabalin Market, by Application(2021-2029) 3.69. Middle East and Africa Pregabalin Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Pregabalin Market (2021-2029) 8.1. Latin America Pregabalin Market, by Product(2021-2029) 8.2. Latin America Pregabalin Market, by Application(2021-2029) 8.3. Latin America Pregabalin Market, by Country (2021-2029) • Brazil • Argentina • Rest Of Latin America 9. European Pregabalin Market (2021-2029) 9.1. European Pregabalin Market, by Product(2021-2029) 9.2. European Pregabalin Market, by Application(2021-2029) 9.3. European Pregabalin Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Pfizer Inc. 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Torrent Pharmaceuticals Ltd. 10.3. Lupin Limited 10.4. Zydus Cadila Healthcare Ltd. 10.5. Cipla Limited 10.6. Genesis Remedies 10.7. Sanofi 10.8. Medley Pharmaceuticals Limited 10.9. Genesis Biotec Inc. 10.10. Biomax 10.11. ZCL Chemicals Ltd. 10.12. Olon S.p.A. 10.13. AASraw Biochemical Technology Co., Ltd. 10.14. Changzhou Pharmaceutical Factory (CPF) 10.15. Almelo Pvt. Ltd. 10.16. Angels Pharma India Pvt. Ltd. 10.17. ARITE Pharmaceutical Co., Ltd. 10.18. Bal Pharma Limited. 10.19. Bazayan and Co. 10.20. Aurobindo Pharma Ltd. 10.21. Hikal Ltd. 10.22. Glenmark Life Sciences 10.23. Dongbang FTL